Mass Tort brief
Bellwether Blows and Discovery Thaws
A $40M catheter award tests Becton Dickinson as federal judges unfreeze stalled multidistrict dockets.
Mass Tort
A $40M bellwether verdict shattered Bard's defense — exposing Becton Dickinson to multibillion-dollar settlement pressure across 4,000 pending catheter claims.
BackgroundImplantable vascular ports are surgically placed under the skin to deliver long-term chemotherapy directly into bloodstream veins. Over 4,000 plaintiffs allege Bard used excessive barium sulfate that degraded catheter tubing, causing catastrophic fractures and cardiac perforation.
- The jury found Bard liable on both negligent design defect and failure-to-warn claims, delivering the first plaintiff victory in MDL 3081.
- Medical evidence demonstrated the fractured Groshong silicone catheter broke into pieces inside the bloodstream, forcing surgeons to perform emergency open cardiac extraction to save the patient.
- The landmark damage award establishes massive settlement leverage for plaintiffs, leaving Becton Dickinson to face thousands of pending federal cases scheduled through early 2027.
Mass Tort
Judge Rowland dissolved the litigation freeze after mediation stalled — compelling cosmetic manufacturers to sit for depositions across 12,000 cancer claims.
BackgroundThousands of Black women filed product liability lawsuits alleging long-term exposure to chemical hair straighteners containing endocrine-disrupting chemicals caused uterine and ovarian cancers. Cosmetic manufacturers insist their products are safe and comply fully with federal cosmetics regulations.
- Judge Rowland ruled that confidential mediation talks lacked sufficient momentum to justify continuing the litigation freeze, requiring executives to submit to sworn depositions.
- The MDL docket remains the fastest-growing mass tort in the country, adding over 350 individual product liability claims over the past month alone.
- Parties are completing contentious Daubert evidentiary hearings over the scientific admissibility of epidemiological studies linking straightener phthalates to reproductive cancers.
Mass Tort
Mass Tort
Spinal stimulator injury claims are consolidating in federal court — threatening Boston Scientific, Abbott, and Nevro with coordinated bellwether trials.
BackgroundSpinal cord stimulators are surgically implanted neurostimulation devices that emit mild electrical pulses to the spinal column to block chronic pain signals. Hundreds of patients allege defective insulation and fragile lead wires cause shocking sensations, nerve scarring, and permanent mobility loss.
- Lawsuits targeting Boston Scientific's WaveWriter Alpha systems allege mechanical lead failures triggered urinary incontinence, muscle spasms, and severe motor dysfunction.
- The Judicial Panel on Multidistrict Litigation scheduled Chicago hearings to decide whether to form companion MDLs for rival devices made by Abbott and Nevro.
- Judge Josephine Staton established master direct-filing dockets in Los Angeles federal court to expedite bellwether discovery and corporate deposition schedules.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
